XENOIMMUNE
Live / Applied — Fourth extension granted (statement of use) (as of 05 Mar 2026)
What this means for you
Not registered yet, but its 14 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97675763
- Mark type
- Stylized text
- Filed
- 14 Nov 2022
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 031 — Natural agricultural products: Live testing animals used to predict the human response to antigens
- Class 042 — Scientific and technological services: Providing serological, cytokines, and immunophenotyping testing services to predict the human response to antigens for scientific purposes
- Class 044 — Medical, beauty and agricultural services: Providing antibody titration testing services to predict the human response to antigens for medical purposes
Owner
- Lapix Therapeutics, Inc., Boston, MA, US
- Lapix Therapeutics, Inc., Boston, MA, US
Prosecution history
- 06 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2026 — SOU EXTENSION 4 GRANTED
- 05 Mar 2026 — SOU EXTENSION 4 FILED
- 05 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2025 — SOU EXTENSION 3 GRANTED
- 04 Sept 2025 — SOU EXTENSION 3 FILED
- 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2025 — SOU EXTENSION 2 GRANTED
- 04 Mar 2025 — SOU EXTENSION 2 FILED
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2024 — SOU EXTENSION 1 GRANTED
- 03 Sept 2024 — SOU EXTENSION 1 FILED